Condition
CTCL/ Mycosis Fungoides
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 3 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06470451Phase 3RecruitingPrimary
Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL
NCT07021495Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
NCT04491825UnknownPrimary
Diagnostic Classifier for Cutaneous T-cell Lymphomas
Showing all 3 trials